Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TREML3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AKR1B10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGKV1OR2-118 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2F1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01600 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEURL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEATR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL18R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNLL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF81 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on